Cite
HARVARD Citation
Alva, G. et al. (n.d.). P3–299: Infrequent skin reactions at the application site of the rivastigmine patch (4.6, 9.5 or 13.3 mg/24 h): Analysis of two clinical studies revealed most were tolerable and manageable across all doses. Alzheimer's & dementia. p. P666. [Online].